SE8602917L - Furosemidsalter - Google Patents
FurosemidsalterInfo
- Publication number
- SE8602917L SE8602917L SE8602917A SE8602917A SE8602917L SE 8602917 L SE8602917 L SE 8602917L SE 8602917 A SE8602917 A SE 8602917A SE 8602917 A SE8602917 A SE 8602917A SE 8602917 L SE8602917 L SE 8602917L
- Authority
- SE
- Sweden
- Prior art keywords
- dosage forms
- furosemide
- bioavailable
- affording
- burden
- Prior art date
Links
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical class C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 abstract 2
- 229960003883 furosemide Drugs 0.000 abstract 2
- FKNQFGJONOIPTF-UHFFFAOYSA-N Sodium cation Chemical compound [Na+] FKNQFGJONOIPTF-UHFFFAOYSA-N 0.000 abstract 1
- 239000002552 dosage form Substances 0.000 abstract 1
- 239000008297 liquid dosage form Substances 0.000 abstract 1
- 239000006186 oral dosage form Substances 0.000 abstract 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 abstract 1
- 229910001415 sodium ion Inorganic materials 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Furan Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/751,763 US4663348A (en) | 1985-07-02 | 1985-07-02 | Furosemide salts and pharmaceutical preparations thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SE8602917D0 SE8602917D0 (sv) | 1986-07-01 |
| SE8602917L true SE8602917L (sv) | 1987-01-03 |
Family
ID=25023379
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE8602917A SE8602917L (sv) | 1985-07-02 | 1986-07-01 | Furosemidsalter |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US4663348A (en, 2012) |
| JP (1) | JPS625975A (en, 2012) |
| AU (1) | AU599034B2 (en, 2012) |
| BE (1) | BE904986A (en, 2012) |
| CH (1) | CH670448A5 (en, 2012) |
| DE (1) | DE3619665A1 (en, 2012) |
| DK (1) | DK312586A (en, 2012) |
| FR (1) | FR2584405B1 (en, 2012) |
| GB (1) | GB2189239B (en, 2012) |
| IT (1) | IT1191972B (en, 2012) |
| LU (1) | LU86484A1 (en, 2012) |
| NL (1) | NL8601519A (en, 2012) |
| SE (1) | SE8602917L (en, 2012) |
| ZA (1) | ZA864207B (en, 2012) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4920145A (en) * | 1988-02-29 | 1990-04-24 | Gaf Chemical Corporation | Water-soluble complexes of water-insoluble pharmaceutical compounds and preparation thereof |
| IT1237115B (it) * | 1989-10-24 | 1993-05-18 | Sali della furosemide, procedimento per la loro preparazione e composizionni farmaceutiche che li contengono | |
| DE69118716T2 (de) * | 1991-12-03 | 1996-12-19 | Kokuyo Kk | Beidseitig zu öffnende/verschliessende vorrichtung zum ordnen |
| US8008283B2 (en) * | 1998-12-23 | 2011-08-30 | Neurotherapeutics Pharma, Inc. | Methods and compositions for the treatment of neuropsychiatric disorders |
| US8722668B2 (en) * | 1998-12-23 | 2014-05-13 | Daryl W. Hochman | Methods and compositions for the treatment of neuropathic pain and neuropsychiatric disorders |
| US7214711B2 (en) * | 1998-12-23 | 2007-05-08 | Neurotherapeutics Pharma Llc | Method of treating migraine headache without aura |
| FI114538B (fi) * | 2001-01-12 | 2004-11-15 | Finnfeeds Finland Ltd | Glysiinibetaiinin käyttö verenpainetta alentavan tuotteen valmistukseen |
| US6989386B2 (en) * | 2002-04-30 | 2006-01-24 | Dana-Farber Cancer Institute | Pharmaceutically active ornithine derivatives, ammonium salts thereof and methods of making same |
| RU2416404C1 (ru) * | 2009-10-05 | 2011-04-20 | Государственное образовательное учреждение высшего профессионального образования "Алтайский государственный медицинский университет Федерального агентства по здравоохранению и социальному развитию" | Средство, обладающее мочегонным действием |
| EP2535342B1 (en) * | 2010-02-10 | 2014-08-06 | Kissei Pharmaceutical Co., Ltd. | Salt of fused heterocyclic derivative and crystal thereof |
| SG11201508251RA (en) * | 2013-04-05 | 2015-11-27 | Scpharmaceuticals Llc | Pharmaceutical formulations for subcutaneous administration of furosemide |
| US11246851B2 (en) | 2019-01-04 | 2022-02-15 | Sq Innovation Ag | Pharmaceutical compositions of furosemide and uses thereof |
| CA3128033A1 (en) | 2019-01-31 | 2020-08-06 | Scpharmaceuticals Inc. | Concentrated liquid pharmaceutical formulations of furosemide and methods of administering the same |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3058882A (en) * | 1959-12-28 | 1962-10-16 | Hoechst Ag | N'-substituted-3-carboxy-6-halo-sulfanilamide and derivatives thereof |
| US3565920A (en) * | 1966-12-29 | 1971-02-23 | Ciba Geigy Corp | 5-sulfamyl-anthranilic acids |
| DK138322B (da) * | 1970-07-13 | 1978-08-14 | Dumex Ltd As | Fremgangsmåde til fremstilling af N-substituered antranilsyrederivater. |
| FR2210607A1 (en) * | 1972-12-20 | 1974-07-12 | Aries Robert | 4-Chloro-5-sulphamoyl-N-furfuryl-anthranilic acid prepn. - from furfural and 4-chloro-5-sulphamoyl anthranilic acid |
| DE2343218C2 (de) * | 1973-08-28 | 1986-08-07 | Hoechst Ag, 6230 Frankfurt | Furosemid enthaltende Pellets |
| LU74319A1 (en, 2012) * | 1976-02-09 | 1977-08-19 | ||
| DE3025367A1 (de) * | 1980-07-04 | 1982-01-28 | Hoechst Ag, 6000 Frankfurt | Salz aus furosemid oder piretanid als saeurekomponente und penbutolol oder (-)-3-(4- (3-(3,4-dimethoxyphenylaethylamino)-2-hydroxy-propoxy) -phenyl ) -crotonsaeurenitril als basenkomponente, verfahren zu seiner herstellung, dieses enthaltendes mittel und dessen verwendung |
-
1985
- 1985-07-02 US US06/751,763 patent/US4663348A/en not_active Expired - Fee Related
-
1986
- 1986-06-05 ZA ZA864207A patent/ZA864207B/xx unknown
- 1986-06-11 NL NL8601519A patent/NL8601519A/nl unknown
- 1986-06-11 DE DE19863619665 patent/DE3619665A1/de not_active Withdrawn
- 1986-06-16 AU AU58890/86A patent/AU599034B2/en not_active Ceased
- 1986-06-20 LU LU86484A patent/LU86484A1/fr unknown
- 1986-06-23 FR FR868609017A patent/FR2584405B1/fr not_active Expired
- 1986-06-23 GB GB08615275A patent/GB2189239B/en not_active Expired
- 1986-06-24 BE BE6/48235A patent/BE904986A/fr not_active IP Right Cessation
- 1986-06-25 IT IT48183/86A patent/IT1191972B/it active
- 1986-06-30 JP JP61151855A patent/JPS625975A/ja active Pending
- 1986-07-01 CH CH2639/86A patent/CH670448A5/fr not_active IP Right Cessation
- 1986-07-01 DK DK312586A patent/DK312586A/da not_active Application Discontinuation
- 1986-07-01 SE SE8602917A patent/SE8602917L/xx not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| GB2189239A (en) | 1987-10-21 |
| AU5889086A (en) | 1987-01-08 |
| NL8601519A (nl) | 1987-02-02 |
| DK312586A (da) | 1987-01-03 |
| IT1191972B (it) | 1988-03-31 |
| GB8615275D0 (en) | 1986-07-30 |
| GB2189239B (en) | 1989-02-01 |
| FR2584405B1 (fr) | 1989-02-24 |
| FR2584405A1 (fr) | 1987-01-09 |
| IT8648183A0 (it) | 1986-06-25 |
| DE3619665A1 (de) | 1987-01-08 |
| US4663348A (en) | 1987-05-05 |
| ZA864207B (en) | 1987-02-25 |
| AU599034B2 (en) | 1990-07-12 |
| BE904986A (fr) | 1986-12-24 |
| SE8602917D0 (sv) | 1986-07-01 |
| JPS625975A (ja) | 1987-01-12 |
| LU86484A1 (fr) | 1986-12-02 |
| DK312586D0 (da) | 1986-07-01 |
| CH670448A5 (en, 2012) | 1989-06-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE8602917D0 (sv) | Furosemidsalter | |
| DE3587941D1 (de) | Gerät zur vorläufigen reperfusionsbehandlung von herzanfallsymptomen. | |
| DK162986D0 (da) | Terapeutisk middel i enhedsdosisform | |
| SE8605515D0 (sv) | A liquid dosage form for oral administration of a pharmaceutically active substance | |
| DE3684121D1 (de) | Pharmazeutische zusammensetzung vom fluessig/gel-phasenuebergangstyp. | |
| NO875299D0 (no) | Insulinpreparat for ikke-paranteral administrasjon. | |
| BG85941A (bg) | Лекарствена форма с контролирано освобождаване и метод за получаването й | |
| NO863029D0 (no) | Farmasoeytisk doseringsenhet. | |
| IT1158048B (it) | Preparato farmaceutico equilibrato idrodinamicamente dotato di cessione protratta della sostanza attiva | |
| FI863971A7 (fi) | Farmaseuttinen koostumus käytettäväksi leukopenian hoidossa. | |
| DE68909409D1 (de) | Heilmitteldosierung zur verabreichung an fische. | |
| IT1180245B (it) | Agenti di contrasto e metodo per il loro uso | |
| EA200200151A1 (ru) | Сухая порошкообразная композиция | |
| DK23386D0 (da) | Pyridopyrimidiner, deres fremstilling og anvendelse som laegemidler | |
| ES2176805T3 (es) | Empleo de mezclas de productos activos para la obtencion de agentes hipocolesterinemicos. | |
| DK515285D0 (da) | Imidazoliumsalte med blodsukker-saenkende virkning og farmaceutiske midler indeholdende saadanne forbindelser | |
| ES478272A1 (es) | Un procedimiento para la preparacion de una solucion acuosa esteril y estable de cisplatina. | |
| ES2082023T3 (es) | Soluciones inyectables listas para su utilizacion que contienen un agente antitumoral del tipo antraciclina glucosido. | |
| MX9203782A (es) | Forma de dosis con capacidad de administracion mejorada. | |
| ES2052670T3 (es) | Utilizacion de derivados de 2-pirimidinil-1-piperazina. | |
| NL188891C (nl) | Farmaceutisch preparaat met bloeddrukverlagende werking dat co-dergocrine en nog een actief materiaal bevat. | |
| IT1060117B (it) | 4 alchil diossi alchilen 5 benzil pirimidine, procedimento per la loro preparazione e preparati medicinali | |
| DE3677181D1 (de) | Wasserfreie, selektive, ionendurchlaessige elektroden zur untersuchung bestimmter ionen in waessrigen loesungen. | |
| DK528386A (da) | Proteinabsorptionsforoegende midler | |
| IT1170342B (it) | Agente farmaceutico per il trattamento di tumori in fase di metastatizzazione e di anemie da labilita' della membrana eritrocitaria |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NAV | Patent application has lapsed |
Ref document number: 8602917-0 Effective date: 19920201 |